Is transition between subtypes of pemphigus possible? A series of pemphigus vulgaris patients showing the transition to pemphigus foliaceus

An Bras Dermatol. 2023 Nov-Dec;98(6):787-792. doi: 10.1016/j.abd.2022.09.012. Epub 2023 Jun 23.

Abstract

Background: Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are subtypes of pemphigus with distinct clinical and laboratory features. The transition between these two subtypes has rarely been reported previously.

Methods: The data of PV patients who exhibited clinical and immunoserological transition to PF during the follow-up period were retrospectively evaluated regarding their demographical, clinical, and laboratory characteristics.

Results: Among 453 patients diagnosed with PV, 13 (2.9%) patients exhibited clinical and immunoserological transition from PV to PF. The mean age of PV patients at the time of diagnosis was 39.8 ± 14.7 (19‒62) years and 7 (53.8%) of them were female. These patients showed clinical and immunoserological transition from PV to PF after a period ranging from 4 months to 13 years (mean 36.2 ± 41 months). In addition to typical clinical features of PF, all patients had positive anti-desmoglein-1 and negative anti-desmoglein-3 antibody levels after the clinical transition had occurred without any mucosal involvement. During a mean 7.8 ± 5.8 (2‒21) years of follow-up period after the transition from PV to PF, only one female patient had experienced a re-transition to PV characterized by a relapse of disease involving mucosal surfaces with positive anti-desmoglein-3 antibody levels following a 5-year period of remission period without treatment.

Study limitations: Single-center study with a retrospective study design.

Conclusion: Our series is the largest group of patients reported to show the transition from PV to PF to date with a long follow-up period. The reason behind the disappearance of anti-desmoglein-3 antibodies and the pathogenesis of this phenomenon is not yet elucidated.

Keywords: Autoimmune diseases; Pemphigus; Skin diseases, vesiculobullous.

MeSH terms

  • Adult
  • Autoantibodies
  • Desmoglein 1
  • Desmoglein 3
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pemphigus* / pathology
  • Retrospective Studies

Substances

  • Autoantibodies
  • Desmoglein 1
  • Desmoglein 3